Tobacco Investments in the Pharmaceutical Sector: Countering the Narrative and Anticipating Other Issues

Overview

The tobacco industry has long interfered with global health policies and regulations at the international level and in countries worldwide. As new actors enter the “harm reduction” space and novel tobacco products emerge, the industry is implementing new strategies to counter regulations and maintain its profits.

While the tobacco industry continues evolving tactics, the response must also advance. This session highlighted the Global Tobacco Industry Interference Index and shared lessons learned in strengthening the implementation of WHO FCTC Article 5.3. so that governments can better overcome industry obstruction, implement effective tobacco control, and build a healthier future for all.